First Randomized Trial of the Stellarex™ Drug-coated Balloon Presented at the Amputation Prevention Symposium
August 10, 2016 17:58 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Aug. 10, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Professor Marianne Brodmann of Medical University Graz, Austria,...
Spectranetics Receives CE Mark for AngioSculptX™
August 10, 2016 09:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Aug. 10, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of CE marking for the AngioSculptX Drug-coated PTCA Scoring Balloon...
Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million
July 28, 2016 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 28, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months ended June 30, 2016. ...
Federal Circuit Court Rules in Appeal
July 21, 2016 13:20 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 21, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that the United States Court of Appeals for the Federal Circuit reversed in...
12-month Results of the ILLUMENATE European Randomized Clinical Trial to be Presented at the Amputation Prevention Symposium
July 20, 2016 09:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 20, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Professor Marianne Brodmann of Medical University Graz, Austria, will...
Spectranetics to Host Second Quarter 2016 Conference Call on July 28, 2016
July 07, 2016 09:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 07, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release second quarter 2016 financial results after the...
Second Interim Analysis on ILLUMENATE Global Study Presented on Spectranetics’ Stellarex drug-coated balloon at NCVH
June 01, 2016 16:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., June 01, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Dr. Prakash Krishnan of Mount Sinai Medical Center, New York, NY...
Spectranetics to Present at the UBS Global Healthcare Conference
May 11, 2016 16:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., May 11, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Chief Financial Officer Stacy McMahan will be presenting at the UBS...
Spectranetics Achieves First Quarter 2016 Revenue of $62.9 million
April 28, 2016 16:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., April 28, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months ended March 31, 2016. ...
12-Month Interim ILLUMENATE Global Study Data Presented on Spectranetics’ Stellarex drug-coated balloon at Charing Cross
April 26, 2016 06:30 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., April 26, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Professor Thomas Zeller presented 12-month interim data from the...